11 May 2023 | Dubai | Amanat Holdings PJSC (“Amanat” or the “Company”) (DFM symbol: AMANAT), the leading healthcare and education listed investment company, announces its financial results for the three months ended 31 March 2023.

  • Revenue: grew by 42%, driven by growth across both healthcare and education, including the contribution from the recently acquired Human Development Company
  • Adjusted EBITDA: increased by 45% year-on-year to AED 70.8 million in Q1 2023
  • Profit for the Period: grew by 46% year-on-year to AED 44.4 million in Q1 2023 driven by strong growth across both the healthcare and education platforms
  • Balance sheet: AED 654 million of cash at the period end and low leverage
  • Value creation: post-period end completed the acquisition of majority stake in Sukoon and launched Amanat Healthcare, with potential regional IPO in the near-term

Commenting on the results, Amanat’s Chairman, Hamad Alshamsi said:

“Our strong financial results for the first three months of 2023 demonstrate the success of our value creation and growth strategies, as our expansion into new businesses and geographic diversification has delivered growth across both our platforms.”

“Post-period end, we completed the acquisition of a majority stake in Sukoon, making Amanat the largest pan-GCC post-acute care provider, with plans underway to deliver 1,000 pan regional beds within the next three years. We also launched Amanat Healthcare, which we expect to unlock additional value for our shareholders, including through inorganic growth opportunities with synergistic benefits. We are currently exploring potential monetization options for Amanat Healthcare, including a regional initial public offering in the near-term.”

Amanat’s Acting Chief Executive Officer, John Ireland, added:

“We maintained our strong earnings momentum in the first quarter of 2023, reflecting the quality and growth potential of our market leading portfolio of healthcare and education assets.”

“Revenue increased 42% year-on-year to AED 185.2 million driven by the addition of Human Development Company (HDC), strong growth at Middlesex supported by higher student enrollment and the increased contribution of KSA to Amanat Healthcare. This strong performance was reflected in our profit for the period which increased 46% to AED 44.4 million.”

Q1 2023 results

The Company recorded revenue of AED 185.2 million in Q1 2023, versus AED 130.8 million in Q1 2022 and operating profit of AED 51.9 million versus AED 33.8 million in Q1 2022. Profit for the period was AED 44.4 million versus AED 30.4 million in Q1 2022 whilst profit attributable to equity shareholders was AED 39.7 million vs. AED 32.0 million in Q1 2022.

Summary Financial Results AED million

Q1 2022

Q1 2023

23 vs. 22

Revenue

130.8

185.2

42%

Adjusted EBITDA

48.7

70.8

45%

Operating Profit

33.8

51.9

54%

Profit for the Period

30.4

44.4

46%

Profit for the Period Attributable to Equity Shareholders

32.0

39.7

24%

Adjusted Profit for the Period Attributable to Equity Shareholders1

32.3

40.1

24%

Cash and Bank Balances2

584

654

12%

1For a reconciliation of alternative measures please refer to the Interim Condensed Consolidated Financial Statements and earnings release.
2 Cash and bank balances include the cash and bank balances of Amanat Holdings PJSC and its subsidiaries. Comparative refers to balance as at 31 December 2022.